Trials / Sponsors / Io Therapeutics
Io Therapeutics
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Suspended | Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis Psoriasis, Plaque Type Psorisis, Plaque Psoriasis | Phase 2 | 2026-03-01 |
| Terminated | Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC Lung Cancer, Nonsmall Cell | Phase 1 | 2016-12-07 |
| Completed | Study of IRX4204 for Treatment of Early Parkinson's Disease Parkinson's Disease | Phase 1 | 2014-08-01 |
| Completed | Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer Castration Resistant Prostate Cancer | Phase 2 | 2011-08-01 |